Skip to main content
. 2017 Jun 9;16:36. doi: 10.1186/s12937-017-0259-0

Table 1.

Baseline characteristics of patients included in the study (n = 42)

Variable Control (n = 21) Intervention (n = 21)
Age (years) 55.0 (9.5) 58.6 (11.0)
Sex
 Male 38.1% (n = 08) 52.4% (n = 11)
 Female 61.9% (n = 13) 47.6% (n = 10)
Income (Reais, R$) 1028.2 (556.9) 1168.9 (602.8)
Schooling
 Illiterate 14.3% (n = 3) 19.0% (n = 4)
 Incomplete elementary school 61.9% (n = 13) 61.9% (n = 13)
 Complete elementary school 14.3% (n = 03) 4.8% (n = 01)
 Incomplete high school 4.8% (n = 01) 9.5% (n = 02)
 High school 4.8% (n = 01) 4.8% (n = 01)
Ejection fraction (%) 45.7(14.8) 44.2(14.0)
Weight (kg) 67.3 (11.3) 69.1 (14.1)
Height (m) 1.56 (0.1) 1.60 (0.1)
Body mass index (kg/m2) 27.7 (5.2) 27.0 (4.7)
Brachial circumference (cm) 29.4 (4.2) 28.3 (3.9)
Triceps skinfold thickness (mm) 18.4 (11.1) 15.1 (7.7)
Brachial muscle circumference (cm) 23.3 (2.6) 23.7 (2.8)
Waist circumference (cm) 87.0 (9.6) 89.0 (12.8)
Hip circumference (cm) 100.4 (10.0) 99.5 (10.9)
Triacylglycerol (mg/dL) 93.8 (39.5) 97.7 (50.9)
Total cholesterol (mg/dL) 166.7 (27.5) 171.7 (38.8)
HDL-cholesterol (mg/dL) 50.4 (13.4) 51.1 (16.2)
LDL-cholesterol (mg/dL) 97.5 (23.2) 105.8 (32.9)
VLDL-cholesterol (mg/dL) 18.8 (8.0) 18.8 (9.1)
Glucose (mg/dL) 93.8 (9.5) 95.6 (8.0)
Tumour necrosis factor-α 66.4 (20.9) 65.6 (19.1)
Interleukin-4 22.2 (6.6) 23.1 (9.2)
Interleukin-6 335.4 (486.9) 163.9 (142.1)
Interleukin-8 84.8 (58.1) 59.8 (26.2)
Interleukin-10 105.2 (71.2) 70.4 (28.4)
Interleukin-33 77.2 (23.6) 86.7 (66.5)
Interleukin-1b 21.1 (8.9) 18.9 (4.4)
Interleukin-17a 5082.3 (5086.2) 3940.4 (4685.9)
Interferon-γ 75.5 (112.9) 47.8 (84.2)

Data are expressed as means (standard deviation) and prevalence of frequency